Plasma B-Type Natriuretic Peptide Levels May Increase Because of Fat Mass Loss by Metformin or Sodium-Glucose Transporter 2 Inhibitors Treatment

Hidetaka Hamasaki, Hidekatsu Yanai
  • Journal of Endocrinology and Metabolism, January 2016, Elmer Press, Inc.
  • DOI: 10.14740/jem333w

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Hidetaka Hamasaki